Latest News

May 13, 2020

Congratulations, Class of 2020!

By Katz Communications

The Lewis Katz School of Medicine’s (LKSOM) 118th commencement was arguably one of its most […]

May 11, 2020

Temple Researchers Uncover Link between Blood Vessel Inflammation and Malfunctioning Cellular Powerhouses

By Katz Communications

The vast majority of cells in the human body contain tiny power plants known as mitochondria that […]

May 8, 2020

148 Temple Physicians Named “Top Doctors” by Philadelphia Magazine

By Katz Communications

One hundred forty eight (148) Temple physicians have been named to Philadelphia magazine’s “Top […]

May 4, 2020

$12 Million NIH Grant Opens Avenues for Temple Researchers to Explore Molecular Basis of Heart Disease and Pursue Innovative Therapies

By Katz Communications

Heart disease is a leading cause of death worldwide. But significant disparities exist in the […]

Apr. 30, 2020

Temple Scientists Regenerate Neurons in Mice with Spinal Cord Injury and Optic Nerve Damage

By Katz Communications

Like power lines in an electrical grid, long wiry projections that grow outward from neurons – […]

Apr. 29, 2020

Temple Now Offering a Variety of Clinical Trials and Investigational Treatment Options for Patients with COVID-19

By Katz Communications

Temple University Hospital is now participating in a variety of clinical trials that are testing […]

Apr. 23, 2020

Temple Researchers Show Protein Produced By Heart in Sepsis Lowers Blood Pressure, Identify Treatment to Reverse its Effects

By Katz Communications

Overreaction is rarely useful, and in the case of the human immune system, it can be outright […]

Apr. 16, 2020

Temple Healthcare Workers Called To Join National PCORnet® Study To Fight COVID-19 Together

By Katz Communications

The Healthcare Worker Exposure Response & Outcomes (HERO) Registry launched this week, inviting […]

Apr. 16, 2020

Temple Students Are Doing Their Part

By Katz Communications

During this global pandemic and uncertain time, students at the Lewis Katz School of Medicine are […]

Apr. 15, 2020

Temple Treats First Patient in the U.S. in Clinical Trial of Gimsilumab for Patients with COVID-19 and Acute Respiratory Distress Syndrome

By Katz Communications

Temple University Hospital has treated the first patient in the United States in the BREATHE […]

Apr. 14, 2020

Temple Researchers Awarded $1.98 Million from NIAID to Investigate T-Cell Activation

By Katz Communications

Switching immune cells on is a critical step in combating infection. In the case of T cells, which […]

Apr. 13, 2020

Students Scour the Region to Help Bridge PPE Gap at Temple

By Katz Communications

Who could have imagined a month ago that Temple University Hospital would be taking delivery of […]

Mar. 30, 2020

Temple Researchers Reverse Muscle Fibrosis from Overuse Injury in Animals, Raising Hope for Clinical Trials in Humans

By Katz Communications

Overuse injuries – think muscle strains, tennis elbow, and rotator cuff tears – are a considerable […]

Mar. 26, 2020

Class of 2020 Experiences a Match Day Like No Other

By Katz Communications

Match Day 2020 at the Lewis Katz School of Medicine was like none other in history. In a normal […]

Mar. 25, 2020

Critical Brake on Immune Activity Identified by Researchers at Temple and Fox Chase Cancer Center, Raising New Possibilities for Anticancer Therapy

By Katz Communications

The immune system is like a carefully regulated machine, complete with its own built-in “brakes” […]

Lewis Katz School of Medicine

Sean Salehi, MD ’96: Innovation by Design

Congratulations, Class of 2020!

Temple Researchers Uncover Link between Blood Vessel Inflammation and Malfunctioning Cellular Powerhouses

148 Temple Physicians Named “Top Doctors” by Philadelphia Magazine

$12 Million NIH Grant Opens Avenues for Temple Researchers to Explore Molecular Basis of Heart Disease and Pursue Innovative Therapies

Temple Scientists Regenerate Neurons in Mice with Spinal Cord Injury and Optic Nerve Damage

Temple Now Offering a Variety of Clinical Trials and Investigational Treatment Options for Patients with COVID-19

Temple Researchers Show Protein Produced By Heart in Sepsis Lowers Blood Pressure, Identify Treatment to Reverse its Effects

Temple Healthcare Workers Called To Join National PCORnet® Study To Fight COVID-19 Together

Temple Students Are Doing Their Part

Temple Treats First Patient in the U.S. in Clinical Trial of Gimsilumab for Patients with COVID-19 and Acute Respiratory Distress Syndrome

Temple Researchers Awarded $1.98 Million from NIAID to Investigate T-Cell Activation

Students Scour the Region to Help Bridge PPE Gap at Temple

Temple Researchers Reverse Muscle Fibrosis from Overuse Injury in Animals, Raising Hope for Clinical Trials in Humans

Class of 2020 Experiences a Match Day Like No Other

Critical Brake on Immune Activity Identified by Researchers at Temple and Fox Chase Cancer Center, Raising New Possibilities for Anticancer Therapy

Temple University
Lewis Katz School of Medicine

Lewis Katz School of Medicine

Sean Salehi, MD ’96: Innovation by Design

Congratulations, Class of 2020!

Temple Researchers Uncover Link between Blood Vessel Inflammation and Malfunctioning Cellular Powerhouses

148 Temple Physicians Named “Top Doctors” by Philadelphia Magazine

$12 Million NIH Grant Opens Avenues for Temple Researchers to Explore Molecular Basis of Heart Disease and Pursue Innovative Therapies

Temple Scientists Regenerate Neurons in Mice with Spinal Cord Injury and Optic Nerve Damage

Temple Now Offering a Variety of Clinical Trials and Investigational Treatment Options for Patients with COVID-19

Temple Researchers Show Protein Produced By Heart in Sepsis Lowers Blood Pressure, Identify Treatment to Reverse its Effects

Temple Healthcare Workers Called To Join National PCORnet® Study To Fight COVID-19 Together

Temple Students Are Doing Their Part

Temple Treats First Patient in the U.S. in Clinical Trial of Gimsilumab for Patients with COVID-19 and Acute Respiratory Distress Syndrome

Temple Researchers Awarded $1.98 Million from NIAID to Investigate T-Cell Activation

Students Scour the Region to Help Bridge PPE Gap at Temple

Temple Researchers Reverse Muscle Fibrosis from Overuse Injury in Animals, Raising Hope for Clinical Trials in Humans

Class of 2020 Experiences a Match Day Like No Other

Critical Brake on Immune Activity Identified by Researchers at Temple and Fox Chase Cancer Center, Raising New Possibilities for Anticancer Therapy

Temple UniversityLewis Katz School of Medicine

Temple University
Lewis Katz School of Medicine